Thursday, January 9, 2014

Link between RNA build-up and dementia, motor neuron disease

 new toxic entity associated with genetically inherited forms of dementia and motor neuron disease has been identified by scientists at the UCL Institute of Neurology. The toxin is the result of a genetic mutation that leads to the production of RNA molecules which could be responsible for the diseases. The findings are published in the journal Acta Neuropathologica.

Frontotemporal dementia and motor neuron disease are related neurodegenerative diseases that affect approximately 15,000 people in the UK. Frontotemporal dementia causes profound personality and behaviour changes. Motor neuron disease leads to muscle weakness and eventual paralysis.

The most common known cause for both frontotemporal dementia and motor neuron disease is an unusual genetic mutation in the C9orf72 gene. The mutation involves a small string of DNA letters at the beginning of the gene, which expand massively to produce thousands of copies.

The new research, funded by Alzheimer's Research UK and the Medical Research Council, has shown that this DNA expansion acts in a peculiar way, leading to the generation of unexpected RNA molecules that could cause the disease.

When a gene is turned on, an RNA copy of the gene's DNA is generated. The gene's DNA code has directionality, so that it is normally turned on in only one direction, termed the 'sense direction'. The new research shows that the DNA expansion is turned on in both directions.

This leads to the normal sense RNA being produced, as well as RNA in the opposite direction, termed 'antisense RNA'. Both RNA types accumulate into aggregates in the neurons of people with frontotemporal dementia.
Intriguingly, the research showed that people with more of these aggregates in their brains developed the disease earlier than people with less RNA aggregates. This correlation suggests that the build-up may be important in causing frontotemporal dementia and motor neuron disease, making the C9orf72 DNA expansion a potential target for therapy.

Dr Adrian Isaacs, lead researcher at the UCL Institute of Neurology, said: ""These findings identify new, potentially toxic molecules in diseases caused by DNA expansions. The next steps will be to determine how they might kill neurons and how to stop them building up."

Dr Simon Ridley, Head of Research at Alzheimer's Research UK, the UK's leading dementia research charity, said: "The discovery of the C9ORF72 gene was a major step forward for research into frontotemporal dementia and motor neuron disease, and it's positive to see researchers beginning to untangle how this gene may cause these diseases in some people.

"Alzheimer's Research UK is delighted to have supported this promising study. By unravelling some of the biological mechanisms at play, this research could take us further on the road to new treatments that are so desperately needed by the thousands of people with these devastating diseases. For these results to reach their full potential it's vital that we continue to invest in research."




Alzheimer's patients at increased risk for heart disease

Persons with Alzheimer's disease suffer from ischaemic heart diseases more frequently than others, yet they undergo related procedures and surgery less frequently than persons with no diagnosed AD, according to a nation-wide register-based study carried out at the University of Eastern Finland.

The study involved a total of 28,093 persons; that is every community-dwelling person with a diagnosed Alzheimer's disease living in Finland on 31 December 2005. According to the data obtained from the national hospital discharge register, persons with Alzheimer's disease were slightly more likely to suffer from ischaemic heart diseases than their matched control group with no existing AD diagnosis. Despite this, persons with Alzheimer's disease underwent significantly fewer procedures restoring cardiac circulation, such as coronary angioplasty and coronary artery bypass surgery, than the control group.

The results were not explained by medical treatment of cardiovascular diseases or by other related diseases such as stroke, diabetes, asthma, or cancer. Severely reduced cognitive function is a relative contraindication for coronary artery bypass surgery, but not for coronary angioplasty. However, the register-based data makes it difficult to assess whether the low number of coronary angioplasties performed on persons with Alzheimer's disease is indicative of their insufficient access to treatment.

The study constituted part of the register-based MEDALZ-2005 project, which focuses on the health of persons with Alzheimer's disease, their use of drugs and health services, and drug safety. The study was published in International Journal of Cardiology.

New hope for Alzheimer's disease offered by S14G-humanin

Humanin is a potential therapeutic agent for Alzheimer's disease, and its derivative, S14G-humanin, is 1 000-fold stronger in its neuroprotective effect against Alzheimer's disease-relevant insults.

Although effective, the detailed molecular mechanism through which S14G-humanin exerts its effects remains unclear.

A recent study by Xue Li and colleagues from Henan Provincial People's Hospital, China investigated the inhibitory effects of S14G-humanin on amyloid-beta protein-induced hippocampal neuronal injury, and data from this study showed that fibrillar amyloid-beta 40 disturbed cellular homeostasis through the cell membrane, increasing intracellular calcium, generating reactive oxygen species, and decreasing the mitochondrial membrane potential.

S14G-humanin blocked the effects of amyloid-beta 40 on the neuronal cell membrane, and restored the disturbed cellular homeostasis, thereby exhibiting a potential and effective treatment for Alzheimer's disease. These findings were

Specific brain regions can be trained by means of video games

Video gaming causes increases in the brain regions responsible for spatial orientation, memory formation and strategic planning as well as fine motor skills. This has been shown in a new study conducted at the Max Planck Institute for Human Development and Charite University Medicine St. Hedwig-Krankenhaus. The positive effects of video gaming may also prove relevant in therapeutic interventions targeting psychiatric disorders.

In order to investigate how video games affect the brain, scientists in Berlin have asked adults to play the video game "Super Mario 64" over a period of two months for 30 minutes a day. A control group did not play video games. Brain volume was quantified using magnetic resonance imaging (MRI). In comparison to the control group the video gaming group showed increases of grey matter, in which the cell bodies of the nerve cells of the brain are situated. These plasticity effects were observed in the right hippocampus, right prefrontal cortex and the cerebellum. These brain regions are involved in functions such as spatial navigation, memory formation, strategic planning and fine motor skills of the hands. Most interestingly, these changes were more pronounced the more desire the participants reported to play the video game.

"While previous studies have shown differences in brain structure of video gamers, the present study can demonstrate the direct causal link between video gaming and a volumetric brain increase. This proves that specific brain regions can be trained by means of video games", says study leader Simone Kühn, senior scientist at the Center for Lifespan Psychology at the Max Planck Institute for Human Development. Therefore Simone Kühn and her colleagues assume that video games could be therapeutically useful for patients with mental disorders in which brain regions are altered or reduced in size, e.g. schizophrenia, post-traumatic stress disorder or neurodegenerative diseases such as Alzheimer's dementia.

"Many patients will accept video games more readily than other medical interventions", adds the psychiatrist Jürgen Gallinat, co-author of the study at Charité University Medicine St. Hedwig-Krankenhaus. Further studies to investigate the effects of video gaming in patients with mental health issues are planned. A study on the effects of video gaming in the treatment of post-traumatic stress disorder is currently ongoing.

The next step in stroke prevention:

As growing numbers of America's baby boomers reach retirement, neuroscientists are expanding their efforts to understand and treat one of the leading health issues affecting this population: age-related neurological deterioration, including stroke and dementia.

One factor coming under increased study is cerebral microbleeds, experienced by nearly 20 percent of people by age 60 and nearly 40 percent by age 80. Research into these small areas of brain bleeding, caused by a breakdown of miniscule blood vessels, is shedding light on how the condition may contribute to these neurological changes.

With microbleeds common in older individuals, physicians need to take it into consideration when treating other brain-related issues, said Dr. Mark Fisher, professor of neurology, anatomy & neurobiology, and pathology & laboratory medicine at UC Irvine. This is especially important with stroke prevention measures, which often involve medications that interfere with blood clotting and could exacerbate microbleeds. Stroke risk escalates with age, especially after 55, making stroke one of the leading causes of disability and death in the elderly.

In two current papers published online in Frontiers in Neurology and Stroke, Fisher writes about the brain's intricate system to protect itself against hemorrhaging. This system seems to break down as we get older, resulting in microbleeds that develop spontaneously and become increasingly common with aging.

"The next step in stroke prevention will require that we address both blood clotting and protection of the blood vessels," he said. "This seems to be the best way to reduce the risk of microbleeds when it's necessary to limit blood clotting for stroke prevention."

In his Stroke article, Fisher describes how newer medications interfere with blood clotting (to protect against stroke) while at the same time protecting the blood vessel wall (to help prevent bleeding). And in Frontiers in Neurology, he suggests that MRI screening be used more strategically to identify patients with microbleeds, allowing their physicians to adjust treatments accordingly.

"With the prevalence of microbleeds, it's important that we better understand this neurological factor as we develop and proceed with brain-related treatments for the elderly," Fisher said. "Identifying and controlling microbleeds may be an important step in a therapeutic approach to maximize brain health during the process of aging. This is a critical issue requiring further study."

Amyloid beta-peptide may worsen cognitive impairment following cerebral ischemia-reperfusion injury

Amyloid beta-peptide, a major component of senile plaques in Alzheimer's disease, has been implicated in neuronal cell death and cognitive impairment.

Recently, studies have shown that the pathogenesis of cerebral ischemia is closely linked with Alzheimer's disease. According to a study, administration of amyloid β-peptide could further aggravate impairments to learning and memory and neuronal cell death in the hippocampus of rats subjected to cerebral ischemia-reperfusion injury.

The synergistic effect of amyloid β-peptide and cerebral ischemia-reperfusion injury exacerbated nerve damage by inducing glycogen synthase kinase 3β and protein phosphatase 2A activity, which resulted in the phosphorylation of tau protein.

This study by Dr. Bo Song and team from Research Center of Stem Cells and Regenerative Medicine, School of Medicine, Tsinghua University, China was published in Neural

Photo therapy may someday cure brain diseases such as Alzheimer's and Parkinson's

Researchers at Chalmers University of Technology in Sweden, together with researchers at the Polish Wroclaw University of Technology, have made a discovery that may lead to the curing of diseases such as Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease (the so called mad cow disease) through photo therapy.

The researchers discovered, as they show in the journal Nature Photonics, that it is possible to distinguish aggregations of the proteins, believed to cause the diseases, from the the well-functioning proteins in the body by using multi-photon laser technique.

"Nobody has talked about using only light to treat these diseases until now. This is a totally new approach and we believe that this might become a breakthrough in the research of diseases such as Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease. We have found a totally new way of discovering these structures using just laser light", says Piotr Hanczyc at Chalmers University of Technology.

If the protein aggregates are removed, the disease is in principle cured. The problem until now has been to detect and remove the aggregates.

The researchers now harbor high hopes that photo acoustic therapy, which is already used for tomography, may be used to remove the malfunctioning proteins. Today amyloid protein aggregates are treated with chemicals, both for detection as well as removal. These chemicals are highly toxic and harmful for those treated.

With multi photon laser the chemical treatment would be unnecessary. Nor would surgery be necessary for removing of aggregates. Due to this discovery it might, thus, be possible to remove the harmful protein without touching the surrounding tissue.

These diseases arise when amyloid beta protein are aggregated in large doses so they start to inhibit proper cellular processes.

Different proteins create different kinds of amyloids, but they generally have the same structure. This makes them different from the well-functioning proteins in the body, which can now be shown by multi photon laser technique.